Meeting
2020 ASCO Quality Care Symposium
Effectiveness of immunotherapy given to cancer patients in the hospitalized setting.
Authors
Mojisola O Araoye
University of Connecticut Department of Internal Medicine, Farmington, CT
Mojisola O Araoye, Brian J. Byrne
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
On-Demand Poster Session: Cost, Value, and Policy
Track
Cost, Value, and Policy
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 38, 2020 (suppl 29; abstr 74)
DOI
10.1200/JCO.2020.38.29_suppl.74
Abstract #
74
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Response to PD-1 and PD-L1 based immunotherapy in MSS advanced colorectal cancer is impacted by metastatic disease sites.
First Author: Marwan Fakih
First Author: Jeddeo Paul
Poster
2017 ASCO Annual Meeting
Phase II clinical trial of atezolizumab (A) in advanced non-small cell lung cancer (NSCLC) patients (pts) previously treated with PD1-directed therapy.
First Author: Saveri Bhattacharya
Poster
2016 ASCO Annual Meeting
Evaluation of toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer (NSCLC).
First Author: Rathi Narayana Pillai